ifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a randomised control trial

Sheffield Teaching Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 100 人开始时间: 2010年9月3日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Histologically confirmed, non-localised prostate cancer (PCa)
•2. Stable disease (stable prostate specific antigen [PSA])
•3. Receiving Androgen suppression therapy (AST) for a minimum period of six months
•4. A willingness to comply with the randomised allocation to intervention and willing to undertake the requirements of the allocated intervention. If allocated to the exercise intervention, willing to aim to achieve 80% compliance to the exercise intervention.

•1. Participation in regular physical activity (defined as purposeful physical activity of a moderate intensity for 30 minutes three or more times per week in the previous six months)
•2. Unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers
•3. Uncontrolled painful or unstable bone lesions
•4. Less than two months post surgical treatment
•5. Any physical, neurological or psychiatric impairment or disease such as dementia, multiple sclerosis, severe arthritis or other condition that would limit the ability to understand and complete the study exercises and complete the required questionnaires, recall and record of dietary information

发起方

Sheffield Teaching Hospitals NHS Foundation Trust (UK)